{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:24:20Z","timestamp":1793157860733,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Botulinum neurotoxins (BoNTs) are the most potent toxins known and cause the life threatening disease botulism. Sensitive and broad detection is extremely challenging due to the toxins\u2019 high potency and molecular heterogeneity with several serotypes and more than 40 subtypes. The toxicity of BoNT is mediated by enzymatic cleavage of different synaptic proteins involved in neurotransmitter release at serotype-specific cleavage sites. Hence, active BoNTs can be monitored and distinguished\n                    <jats:italic>in vitro<\/jats:italic>\n                    by detecting their substrate cleavage products. In this work, we developed a comprehensive panel of monoclonal neoepitope antibodies (Neo-mAbs) highly specific for the newly generated N- and\/or C-termini of the substrate cleavage products of BoNT serotypes A to F. The Neo-mAbs were implemented in a set of three enzymatic assays for the simultaneous detection of two BoNT serotypes each by monitoring substrate cleavage on colour-coded magnetic Luminex-beads. For the first time, all relevant serotypes could be detected in parallel by a routine\n                    <jats:italic>in vitro<\/jats:italic>\n                    activity assay in spiked serum and food samples yielding excellent detection limits in the range of the mouse bioassay or better (0.3\u201380\u2009pg\/mL). Therefore, this work represents a major step towards the replacement of the mouse bioassay for botulism diagnostics.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-41722-z","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T06:03:17Z","timestamp":1554184997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology"],"prefix":"10.1038","volume":"9","author":[{"given":"Laura","family":"von Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-4283","authenticated-orcid":false,"given":"Daniel","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mahrhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Weisemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Hansbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Avondet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-1641","authenticated-orcid":false,"given":"Andreas","family":"Rummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Dorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte G.","family":"Dorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"41722_CR1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/mr.46.1.86-94.1982","volume":"46","author":"DM Gill","year":"1982","unstructured":"Gill, D. M. Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 46, 86\u201394 (1982).","journal-title":"Microbiol. Rev."},{"key":"41722_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrmicro3295","volume":"12","author":"O Rossetto","year":"2014","unstructured":"Rossetto, O., Pirazzini, M. & Montecucco, C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat. Rev. Microbiol. 12, 535\u2013549 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"41722_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0072-9752(07)01511-4","volume":"91","author":"EA Johnson","year":"2008","unstructured":"Johnson, E. A. & Montecucco, C. Botulism. Handb. Clin. Neurol. 91, 333\u2013368 (2008).","journal-title":"Handb. Clin. Neurol."},{"key":"41722_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrneurol.2010.149","volume":"6","author":"EC Lim","year":"2010","unstructured":"Lim, E. C. & Seet, R. C. Use of botulinum toxin in the neurology clinic. Nat. Rev. Neurol. 6, 624\u2013636 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"41722_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.det.2013.09.009","volume":"32","author":"A Dorizas","year":"2014","unstructured":"Dorizas, A., Krueger, N. & Sadick, N. S. Aesthetic uses of the botulinum toxin. Dermatol. Clin. 32, 23\u201336 (2014).","journal-title":"Dermatol. Clin."},{"key":"41722_CR6","first-page":"1","volume":"364","author":"KK Hill","year":"2013","unstructured":"Hill, K. K. & Smith, T. J. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr. Top. Microbiol. Immunol. 364, 1\u201320 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"41722_CR7","doi-asserted-by":"publisher","first-page":"e02131","DOI":"10.1128\/mBio.02131-14","volume":"6","author":"C Montecucco","year":"2015","unstructured":"Montecucco, C. & Rasotto, M. B. On botulinum neurotoxin variability. MBio 6, e02131\u201302114 (2015).","journal-title":"MBio"},{"issue":"Part A","key":"41722_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxicon.2015.09.009","volume":"107","author":"A Rummel","year":"2015","unstructured":"Rummel, A. The long journey of botulinum neurotoxins into the synapse. Toxicon 107(Part A), 9\u201324 (2015).","journal-title":"Toxicon"},{"key":"41722_CR9","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.3390\/toxins9010038","volume":"9","author":"MW Peck","year":"2017","unstructured":"Peck, M. W. et al. Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature. Toxins (Basel) 9, E38 (2017).","journal-title":"Toxins (Basel)"},{"key":"41722_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/infdis\/jit450","volume":"209","author":"N Dover","year":"2014","unstructured":"Dover, N., Barash, J. R., Hill, K. K., Xie, G. & Arnon, S. S. Molecular characterization of a novel botulinum neurotoxin type H gene. J. Infect. Dis. 209, 192\u2013202 (2014).","journal-title":"J. Infect. Dis."},{"key":"41722_CR11","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1021\/ac504716v","volume":"87","author":"SR Kalb","year":"2015","unstructured":"Kalb, S. R. et al. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F\/A). Anal. Chem. 87, 3911\u20133917 (2015).","journal-title":"Anal. Chem."},{"key":"41722_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/infdis\/jiv327","volume":"213","author":"SE Maslanka","year":"2016","unstructured":"Maslanka, S. E. et al. A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. J. Infect. Dis. 213, 379\u2013385 (2016).","journal-title":"J. Infect. Dis."},{"key":"41722_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14130","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Identification and characterization of a novel botulinum neurotoxin. Nat. Commun. 8, 14130 (2017).","journal-title":"Nat. Commun."},{"key":"41722_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chom.2017.12.018","volume":"23","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Identification of a botulinum neurotoxin-like toxin in a commensal strain of Enterococcus faecium. Cell Host Microbe 23, 169\u2013176.e166 (2018).","journal-title":"Cell Host Microbe"},{"key":"41722_CR15","doi-asserted-by":"publisher","unstructured":"Brunt, J., Carter, A. T., Stringer, S. C. & Peck, M. W. Identification of a novel botulinum neurotoxin gene cluster in Enterococcus. FEBS Lett, https:\/\/doi.org\/10.1002\/1873-3468.12969 (2018).","DOI":"10.1002\/1873-3468.12969"},{"key":"41722_CR16","doi-asserted-by":"crossref","unstructured":"Williamson, C. H. D. et al. Differentiating botulinum neurotoxin-producing clostridia with a simple, multiplex PCR assay. Appl. Environ. Microbiol. 83 (2017).","DOI":"10.1128\/AEM.00806-17"},{"key":"41722_CR17","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1021\/bi801686b","volume":"48","author":"JS Henkel","year":"2009","unstructured":"Henkel, J. S. et al. Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 48, 2522\u20132528 (2009).","journal-title":"Biochemistry"},{"key":"41722_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00216-012-5767-3","volume":"403","author":"SR Kalb","year":"2012","unstructured":"Kalb, S. R. et al. De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Anal. Bioanal. Chem. 403, 215\u2013226 (2012).","journal-title":"Anal. Bioanal. Chem."},{"key":"41722_CR19","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.bbapap.2013.09.007","volume":"1834","author":"D Wang","year":"2013","unstructured":"Wang, D. et al. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5. Biochim. Biophys. Acta 1834, 2722\u20132728 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"41722_CR20","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1128\/IAI.00536-13","volume":"81","author":"RC Whitemarsh","year":"2013","unstructured":"Whitemarsh, R. C. et al. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro. Infect. Immun. 81, 3894\u20133902 (2013).","journal-title":"Infect. Immun."},{"key":"41722_CR21","doi-asserted-by":"publisher","first-page":"e0116381","DOI":"10.1371\/journal.pone.0116381","volume":"10","author":"S Kull","year":"2015","unstructured":"Kull, S. et al. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype. PLoS One 10, e0116381 (2015).","journal-title":"PLoS One"},{"key":"41722_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.toxicon.2008.12.027","volume":"54","author":"AT Brunger","year":"2009","unstructured":"Brunger, A. T. & Rummel, A. Receptor and substrate interactions of clostridial neurotoxins. Toxicon 54, 550\u2013560 (2009).","journal-title":"Toxicon"},{"key":"41722_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0968-0004(86)90282-3","volume":"11","author":"C Montecucco","year":"1986","unstructured":"Montecucco, C. How do tetanus and botulinum toxins bind to neuronal membranes. Trends Biochem. Sci. 11, 314\u2013317 (1986).","journal-title":"Trends Biochem. Sci."},{"key":"41722_CR24","first-page":"61","volume":"364","author":"A Rummel","year":"2013","unstructured":"Rummel, A. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr. Top. Microbiol. Immunol. 364, 61\u201390 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"41722_CR25","doi-asserted-by":"publisher","unstructured":"Rummel, A. Two feet on the membrane: Uptake of clostridial neurotoxins. Curr. Top. Microbiol. Immunol, https:\/\/doi.org\/10.1007\/82_2016_48, 1\u201337 (2016).","DOI":"10.1007\/82_2016_48"},{"key":"41722_CR26","first-page":"139","volume":"364","author":"T Binz","year":"2013","unstructured":"Binz, T. Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission. Curr. Top. Microbiol. Immunol. 364, 139\u2013157 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"41722_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00018-013-1380-7","volume":"71","author":"S Pantano","year":"2014","unstructured":"Pantano, S. & Montecucco, C. The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell. Mol. Life Sci. 71, 793\u2013811 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"41722_CR28","doi-asserted-by":"publisher","first-page":"10566","DOI":"10.1074\/jbc.270.18.10566","volume":"270","author":"G Schiavo","year":"1995","unstructured":"Schiavo, G., Shone, C. C., Bennett, M. K., Scheller, R. H. & Montecucco, C. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270, 10566\u201310570 (1995).","journal-title":"J. Biol. Chem."},{"key":"41722_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","volume":"80","author":"G Schiavo","year":"2000","unstructured":"Schiavo, G., Matteoli, M. & Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717\u2013766 (2000).","journal-title":"Physiol. Rev."},{"key":"41722_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.febslet.2011.11.033","volume":"586","author":"SR Kalb","year":"2012","unstructured":"Kalb, S. R. et al. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett. 586, 109\u2013115 (2012).","journal-title":"FEBS Lett."},{"key":"41722_CR31","first-page":"219","volume":"364","author":"MB Dorner","year":"2013","unstructured":"Dorner, M. B., Schulz, K. M., Kull, S. & Dorner, B. G. Complexity of botulinum neurotoxins: challenges for detection technology. Curr. Top. Microbiol. Immunol. 364, 219\u2013255 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"41722_CR32","first-page":"375","volume":"131","author":"D Stern","year":"2018","unstructured":"Stern, D., von Berg, L., Skiba, M., Dorner, M. B. & Dorner, B. G. Replacing the mouse bioassay for diagnostics and potency testing of botulinum neurotoxins \u2013 progress and challenges. Berl. Munch. Tierarztl. Wochenschr. 131, 375\u2013394 (2018).","journal-title":"Berl. Munch. Tierarztl. Wochenschr."},{"key":"41722_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1128\/CMR.19.2.298-314.2006","volume":"19","author":"M Lindstr\u00f6m","year":"2006","unstructured":"Lindstr\u00f6m, M. & Korkeala, H. Laboratory diagnostics of botulism. Clin. Microbiol. Rev. 19, 298\u2013314 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"41722_CR34","first-page":"5035","volume-title":"Toxins (Basel)","author":"J Weisemann","year":"2015","unstructured":"Weisemann, J. et al. Generation and characterization of six recombinant botulinum neurotoxins as reference material to serve in an international proficiency test. Toxins (Basel) 7, (5035\u20135054 (2015)."},{"key":"41722_CR35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/mr.44.3.419-448.1980","volume":"44","author":"H Sugiyama","year":"1980","unstructured":"Sugiyama, H. Clostridium botulinum neurotoxin. Microbiol. Rev. 44, 419\u2013448 (1980).","journal-title":"Microbiol. Rev."},{"key":"41722_CR36","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1242\/jcs.103564","volume":"125","author":"L Peng","year":"2012","unstructured":"Peng, L. et al. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. J. Cell Sci. 125, 3233\u20133242 (2012).","journal-title":"J. Cell Sci."},{"key":"41722_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","volume":"586","author":"J Strotmeier","year":"2012","unstructured":"Strotmeier, J., Willjes, G., Binz, T. & Rummel, A. Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity. FEBS Lett. 586, 310\u2013313 (2012).","journal-title":"FEBS Lett."},{"key":"41722_CR38","first-page":"1489","volume":"280","author":"JA Coffield","year":"1997","unstructured":"Coffield, J. A. et al. In vitro characterization of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches. J. Pharmacol. Exp. Ther. 280, 1489\u20131498 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"41722_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/toxins2010024","volume":"2","author":"P \u010capek","year":"2010","unstructured":"\u010capek, P. & Dickerson, T. J. Sensing the deadliest toxin: technologies for botulinum neurotoxin detection. Toxins (Basel) 2, 24\u201353 (2010).","journal-title":"Toxins (Basel)"},{"key":"41722_CR40","first-page":"257","volume":"364","author":"S Pellett","year":"2013","unstructured":"Pellett, S. Progress in cell based assays for botulinum neurotoxin detection. Curr. Top. Microbiol. Immunol. 364, 257\u2013285 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"41722_CR41","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1021\/ac050485f","volume":"77","author":"AE Boyer","year":"2005","unstructured":"Boyer, A. E. et al. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal. Chem. 77, 3916\u20133924 (2005).","journal-title":"Anal. Chem."},{"key":"41722_CR42","first-page":"3497","volume-title":"Toxins (Basel)","author":"S Kalb","year":"2015","unstructured":"Kalb, S., Boyer, A. & Barr, J. Mass spectrometric detection of bacterial protein toxins and their enzymatic activity. Toxins (Basel) 7, (3497\u20133511 (2015)."},{"key":"41722_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/abio.2001.5028","volume":"291","author":"C Anne","year":"2001","unstructured":"Anne, C., Cornille, F., Lenoir, C. & Roques, B. P. High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity. Anal. Biochem. 291, 253\u2013261 (2001).","journal-title":"Anal. Biochem."},{"key":"41722_CR44","first-page":"491","volume":"46","author":"V Parpura","year":"2005","unstructured":"Parpura, V. & Chapman, E. R. Detection of botulinum toxins: micromechanical and fluorescence-based sensors. Croat. Med. J. 46, 491\u2013497 (2005).","journal-title":"Croat. Med. J."},{"key":"41722_CR45","doi-asserted-by":"publisher","first-page":"e2041","DOI":"10.1371\/journal.pone.0002041","volume":"3","author":"K Bagramyan","year":"2008","unstructured":"Bagramyan, K., Barash, J. R., Arnon, S. S. & Kalkum, M. Attomolar detection of botulinum toxin type A in complex biological matrices. PLoS One 3, e2041 (2008).","journal-title":"PLoS One"},{"key":"41722_CR46","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1128\/AEM.00617-08","volume":"74","author":"R Rasooly","year":"2008","unstructured":"Rasooly, R. & Do, P. M. Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A. Appl. Environ. Microbiol. 74, 4309\u20134313 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"41722_CR47","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1128\/AEM.01664-12","volume":"78","author":"FM Dunning","year":"2012","unstructured":"Dunning, F. M. et al. Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity. Appl. Environ. Microbiol. 78, 7687\u20137697 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"41722_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ab.2011.01.002","volume":"411","author":"DR Ruge","year":"2011","unstructured":"Ruge, D. R. et al. Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters. Anal. Biochem. 411, 200\u2013209 (2011).","journal-title":"Anal. Biochem."},{"key":"41722_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/1087057113476089","volume":"18","author":"T Ouimet","year":"2013","unstructured":"Ouimet, T., Duquesnoy, S., Poras, H., Fournie-Zaluski, M. C. & Roques, B. P. Comparison of fluorigenic peptide substrates PL50, SNAPTide, and BoTest A\/E for BoNT\/A detection and quantification: exosite binding confers high-assay sensitivity. J. Biomol. Screen. 18, 726\u2013735 (2013).","journal-title":"J. Biomol. Screen."},{"key":"41722_CR50","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1073\/pnas.0914358107","volume":"107","author":"X Hu","year":"2010","unstructured":"Hu, X., Kang, S., Lefort, C., Kim, M. & Jin, M. M. Combinatorial libraries against libraries for selecting neoepitope activation-specific antibodies. Proc. Natl. Acad. Sci. USA 107, 6252\u20136257 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"41722_CR51","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/jcm.34.8.1934-1938.1996","volume":"34","author":"B Hallis","year":"1996","unstructured":"Hallis, B., James, B. A. & Shone, C. C. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J. Clin. Microbiol. 34, 1934\u20131938 (1996).","journal-title":"J. Clin. Microbiol."},{"key":"41722_CR52","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1574-695X.1999.tb01300.x","volume":"24","author":"M Wictome","year":"1999","unstructured":"Wictome, M. et al. Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunol. Med. Microbiol. 24, 319\u2013323 (1999).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"41722_CR53","doi-asserted-by":"publisher","unstructured":"Evans, C., Howes, D., Pickett, W. & Dagnone, L. Audit filters for improving processes of care and clinical outcomes in trauma systems. Cochrane Database Syst Rev, https:\/\/doi.org\/10.1002\/14651858.CD007590.pub2, CD007590 (2009).","DOI":"10.1002\/14651858.CD007590.pub2"},{"key":"41722_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2009.01.001","volume":"343","author":"RG Jones","year":"2009","unstructured":"Jones, R. G., Liu, Y. & Sesardic, D. New highly specific botulinum type C1 endopeptidase immunoassays utilising SNAP25 or Syntaxin substrates. J. Immunol. Methods 343, 21\u201327 (2009).","journal-title":"J. Immunol. Methods"},{"key":"41722_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jim.2007.09.014","volume":"329","author":"RG Jones","year":"2008","unstructured":"Jones, R. G., Ochiai, M., Liu, Y., Ekong, T. & Sesardic, D. Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. J. Immunol. Methods 329, 92\u2013101 (2008).","journal-title":"J. Immunol. Methods"},{"key":"41722_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tiv.2018.01.016","volume":"48","author":"B Gray","year":"2018","unstructured":"Gray, B., Cadd, V., Elliott, M. & Beard, M. The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent. Toxicol. In Vitro 48, 255\u2013261 (2018).","journal-title":"Toxicol. In Vitro"},{"key":"41722_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tiv.2016.03.011","volume":"34","author":"E Wild","year":"2016","unstructured":"Wild, E. et al. In vitro potency determination of botulinum neurotoxin B based on its receptor-binding and proteolytic characteristics. Toxicol. In Vitro 34, 97\u2013104 (2016).","journal-title":"Toxicol. In Vitro"},{"key":"41722_CR58","doi-asserted-by":"crossref","unstructured":"Simon, S. et al. Recommended immunological strategies to screen for botulinum neurotoxin-containing samples. Toxins (Basel) 7, 5011-5034 (2015).","DOI":"10.3390\/toxins7124860"},{"key":"41722_CR59","first-page":"4935","volume-title":"Toxins (Basel)","author":"S Worbs","year":"2015","unstructured":"Worbs, S. et al. Qualitative and quantitative detection of botulinum neurotoxins from complex matrices: Results of the first international proficiency test. Toxins (Basel) 7, (4935\u20134966 (2015)."},{"key":"41722_CR60","doi-asserted-by":"publisher","first-page":"e49516","DOI":"10.1371\/journal.pone.0049516","volume":"7","author":"E Fernandez-Salas","year":"2012","unstructured":"Fernandez-Salas, E. et al. Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay. PLoS One 7, e49516 (2012).","journal-title":"PLoS One"},{"key":"41722_CR61","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1099\/jmm.0.053124-0","volume":"62","author":"RGA Jones","year":"2013","unstructured":"Jones, R. G. A. & Marks, J. D. Use of a new functional dual coating (FDC) assay to measure low toxin levels in serum and food samples following an outbreak of human botulism. J. Med. Microbiol. 62, 828\u2013835 (2013).","journal-title":"J. Med. Microbiol."},{"key":"41722_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bios.2014.02.015","volume":"57","author":"C L\u00e9v\u00eaque","year":"2014","unstructured":"L\u00e9v\u00eaque, C. et al. Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism. Biosens. Bioelectron. 57, 207\u2013212 (2014).","journal-title":"Biosens. Bioelectron."},{"key":"41722_CR63","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00253-015-6438-z","volume":"99","author":"C L\u00e9v\u00eaque","year":"2015","unstructured":"L\u00e9v\u00eaque, C. et al. A chip-based assay for botulinum neurotoxin A activity in pharmaceutical preparations. Appl. Microbiol. Biotechnol. 99, 4355\u20134360 (2015).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"41722_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ab.2012.02.038","volume":"425","author":"YY Liu","year":"2012","unstructured":"Liu, Y. Y., Rigsby, P., Sesardic, D., Marks, J. D. & Jones, R. G. A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 test. Anal. Biochem. 425, 28\u201335 (2012).","journal-title":"Anal. Biochem."},{"key":"41722_CR65","first-page":"2354","volume-title":"Toxins (Basel)","author":"C Rh\u00e9aume","year":"2015","unstructured":"Rh\u00e9aume, C. et al. A highly specific monoclonal antibody for botulinum neurotoxin type A-cleaved SNAP25. Toxins (Basel) 7, (2354 (2015)."},{"key":"41722_CR66","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0022-1759(00)00238-6","volume":"243","author":"DAA Vignali","year":"2000","unstructured":"Vignali, D. A. A. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243, 243\u2013255 (2000).","journal-title":"J. Immunol. Methods"},{"key":"41722_CR67","doi-asserted-by":"publisher","first-page":"e95188","DOI":"10.1371\/journal.pone.0095188","volume":"9","author":"RM Mizanur","year":"2014","unstructured":"Mizanur, R. M., Stafford, R. G. & Ahmed, S. A. Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin. PLoS One 9, e95188 (2014).","journal-title":"PLoS One"},{"key":"41722_CR68","doi-asserted-by":"publisher","first-page":"e5355","DOI":"10.1371\/journal.pone.0005355","volume":"4","author":"SR Kalb","year":"2009","unstructured":"Kalb, S. R. et al. Extraction and inhibition of enzymatic activity of botulinum neurotoxins\/A1, \/A2, and \/A3 by a panel of monoclonal anti-BoNT\/A antibodies. PLoS One 4, e5355 (2009).","journal-title":"PLoS One"},{"key":"41722_CR69","unstructured":"Russell, W. M. S. & Burch, R. L. The principles of humane experimental technique. (Methuen, 1959)."},{"key":"41722_CR70","first-page":"33","volume":"276","author":"The European Parliament and the Council of the European Union","year":"2010","unstructured":"The European Parliament and the Council of the European Union. Directive 2010\/63\/EU of The European Parliament and of The Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union L 276, 33\u201379 (2010).","journal-title":"Official Journal of the European Union L"},{"key":"41722_CR71","first-page":"4895","volume-title":"Toxins (Basel)","author":"H Bigalke","year":"2015","unstructured":"Bigalke, H. & Rummel, A. Botulinum neurotoxins: Qualitative and quantitative analysis using the mouse phrenic nerve hemidiaphragm assay (MPN). Toxins (Basel) 7, (4895\u20134905 (2015)."},{"issue":"Part B","key":"41722_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.trac.2016.05.024","volume":"85","author":"BG Dorner","year":"2016","unstructured":"Dorner, B. G. et al. Biological toxins of potential bioterrorism risk: Current status of detection and identification technology. Trends Analyt. Chem. 85(Part B), 89\u2013102 (2016).","journal-title":"Trends Analyt. Chem."},{"key":"41722_CR73","first-page":"1765","volume-title":"Toxins (Basel)","author":"S Kalb","year":"2015","unstructured":"Kalb, S., Baudys, J., Wang, D. & Barr, J. Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples. Toxins (Basel) 7, (1765\u20131778 (2015)."},{"key":"41722_CR74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/alzrt261","volume":"6","author":"H Feinberg","year":"2014","unstructured":"Feinberg, H. et al. Crystal structure reveals conservation of amyloid-beta conformation recognized by 3D6 following humanization to bapineuzumab. Alzheimers Res. Ther. 6, 31 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"41722_CR75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/adt.2009.0208","volume":"8","author":"IH Khan","year":"2010","unstructured":"Khan, I. H. et al. Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cells. Assay Drug Dev. Technol. 8, 27\u201336 (2010).","journal-title":"Assay Drug Dev. Technol."},{"key":"41722_CR76","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/adt.2009.0255","volume":"8","author":"M Campbell","year":"2010","unstructured":"Campbell, M. et al. Multiplex analysis of Src family kinase signaling by microbead suspension arrays. Assay Drug Dev. Technol. 8, 488\u2013496 (2010).","journal-title":"Assay Drug Dev. Technol."},{"key":"41722_CR77","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1039\/C6AN00693K","volume":"141","author":"E-M Hansbauer","year":"2016","unstructured":"Hansbauer, E.-M. et al. Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry. Analyst 141, 5281\u20135297 (2016).","journal-title":"Analyst"},{"key":"41722_CR78","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1039\/c3an00525a","volume":"138","author":"GB Stevens","year":"2013","unstructured":"Stevens, G. B. et al. Bioluminescence assay for the highly sensitive detection of botulinum neurotoxin A activity. Analyst 138, 6154\u20136162 (2013).","journal-title":"Analyst"},{"key":"41722_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep17953","volume":"5","author":"C L\u00e9v\u00eaque","year":"2015","unstructured":"L\u00e9v\u00eaque, C. et al. An optical biosensor assay for rapid dual detection of botulinum neurotoxins A and E. Sci. Rep. 5, 17953 (2015).","journal-title":"Sci. Rep."},{"key":"41722_CR80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ab.2010.11.045","volume":"410","author":"G Ferracci","year":"2011","unstructured":"Ferracci, G. et al. A label-free biosensor assay for botulinum neurotoxin B in food and human serum. Anal. Biochem. 410, 281\u2013288 (2011).","journal-title":"Anal. Biochem."},{"key":"41722_CR81","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bios.2013.05.032","volume":"49","author":"C L\u00e9v\u00eaque","year":"2013","unstructured":"L\u00e9v\u00eaque, C. et al. A substrate sensor chip to assay the enzymatic activity of botulinum neurotoxin A. Biosens. Bioelectron. 49, 276\u2013281 (2013).","journal-title":"Biosens. Bioelectron."},{"key":"41722_CR82","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.taap.2008.09.005","volume":"233","author":"S Marconi","year":"2008","unstructured":"Marconi, S. et al. A protein chip membrane-capture assay for botulinum neurotoxin activity. Toxicol. Appl. Pharmacol. 233, 439\u2013446 (2008).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"41722_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tiv.2018.07.008","volume":"53","author":"HA Behrensdorf-Nicol","year":"2018","unstructured":"Behrensdorf-Nicol, H. A. et al. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics. Toxicol. In Vitro 53, 80\u201388 (2018).","journal-title":"Toxicol. In Vitro"},{"key":"41722_CR84","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1016\/j.vaccine.2013.10.028","volume":"31","author":"HA Behrensdorf-Nicol","year":"2013","unstructured":"Behrensdorf-Nicol, H. A., Bonifas, U., Hanschmann, K. M., Kramer, B. & Weisser, K. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production. Vaccine 31, 6247\u20136253 (2013).","journal-title":"Vaccine"},{"key":"41722_CR85","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1042\/BCJ20160439","volume":"473","author":"S Mahrhold","year":"2016","unstructured":"Mahrhold, S. et al. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1. Biochem. J. 473, 2645\u20132654 (2016).","journal-title":"Biochem. J."},{"key":"41722_CR86","doi-asserted-by":"crossref","unstructured":"Weisemann, J., Stern, D., Mahrhold, S., Dorner, B. G. & Rummel, A. Botulinum neurotoxin serotype A recognizes its protein receptor SV2 by a different mechanism than botulinum neurotoxin B synaptotagmin. Toxins (Basel) 8, pii: E154 (2016).","DOI":"10.3390\/toxins8050154"},{"key":"41722_CR87","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1365-2672.2009.04325.x","volume":"107","author":"ER Evans","year":"2009","unstructured":"Evans, E. R., Skipper, P. J. & Shone, C. C. An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin. J. Appl. Microbiol. 107, 1384\u20131391 (2009).","journal-title":"J. Appl. Microbiol."},{"key":"41722_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.vascn.2013.12.002","volume":"69","author":"RW Gregory","year":"2014","unstructured":"Gregory, R. W., Werner, W. E. & Ruegg, C. A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A. J. Pharmacol. Toxicol. Methods 69, 103\u2013107 (2014).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"41722_CR89","doi-asserted-by":"crossref","unstructured":"Rosen, O., Ozeri, E., Barnea, A., David, A. B. & Zichel, R. Development of an innovative in vitro potency assay for anti-botulinum antitoxins. Toxins (Basel) 8, pii: E276 (2016).","DOI":"10.3390\/toxins8100276"},{"key":"41722_CR90","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fphar.2017.00796","volume":"8","author":"A Rust","year":"2017","unstructured":"Rust, A. et al. A cell line for detection of botulinum neurotoxin type B. Front. Pharmacol. 8, 796 (2017).","journal-title":"Front. Pharmacol."},{"key":"41722_CR91","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nsmb.3245","volume":"23","author":"G Yao","year":"2016","unstructured":"Yao, G. et al. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Nat. Struct. Mol. Biol. 23, 656\u2013662 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"41722_CR92","doi-asserted-by":"publisher","first-page":"e1007048","DOI":"10.1371\/journal.ppat.1007048","volume":"14","author":"D Stern","year":"2018","unstructured":"Stern, D. et al. A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency. PLoS Pathog. 14, e1007048 (2018).","journal-title":"PLoS Pathog."},{"key":"41722_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01534-z","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC. Nat. Commun. 8, 1637 (2017).","journal-title":"Nat. Commun."},{"key":"41722_CR94","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-695X.2010.00774.x","volume":"61","author":"H Moura","year":"2011","unstructured":"Moura, H. et al. Studies on botulinum neurotoxins type \/C1 and mosaic\/DC using Endopep-MS and proteomics. FEMS Immunol. Med. Microbiol. 61, 288\u2013300 (2011).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"41722_CR95","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0021-9258(17)42071-0","volume":"269","author":"T Binz","year":"1994","unstructured":"Binz, T. et al. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269, 1617\u20131620 (1994).","journal-title":"J. Biol. Chem."},{"key":"41722_CR96","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1039\/b911525k","volume":"134","author":"D Pauly","year":"2009","unstructured":"Pauly, D. et al. Simultaneous quantification of five bacterial and plant toxins from complex matrices using a multiplexed fluorescent magnetic suspension assay. Analyst 134, 2028\u20132039 (2009).","journal-title":"Analyst"},{"key":"41722_CR97","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680\u2013685 (1970).","journal-title":"Nature"},{"key":"41722_CR98","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/elps.1150090603","volume":"9","author":"V Neuhoff","year":"1988","unstructured":"Neuhoff, V., Arold, N., Taube, D. & Ehrhardt, W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9, 255\u2013262 (1988).","journal-title":"Electrophoresis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41722-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:32:10Z","timestamp":1671247930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41722-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41722"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41722-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5531"}}